These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10429009)

  • 1. How do we safely use inhaled nitric oxide?
    Clark RH
    Pediatrics; 1999 Aug; 104(2 Pt 1):296-7. PubMed ID: 10429009
    [No Abstract]   [Full Text] [Related]  

  • 2. Is Administration of Nitric Oxide During Extracorporeal Membrane Oxygenation Associated With Improved Patient Survival?
    Tadphale SD; Rettiganti M; Gossett JM; Beam BW; Padiyath A; Schmitz ML; Gupta P
    Pediatr Crit Care Med; 2016 Nov; 17(11):1080-1087. PubMed ID: 27632059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up.
    Clark RH; Huckaby JL; Kueser TJ; Walker MW; Southgate WM; Perez JA; Roy BJ; Keszler M;
    J Perinatol; 2003 Jun; 23(4):300-3. PubMed ID: 12774137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of withdrawing inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn.
    Davidson D; Barefield ES; Kattwinkel J; Dudell G; Damask M; Straube R; Rhines J; Chang CT
    Pediatrics; 1999 Aug; 104(2 Pt 1):231-6. PubMed ID: 10429000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of inhaled nitric oxide in newborn medicine.
    Golombek SG
    Heart Dis; 2000; 2(5):342-7. PubMed ID: 11728280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipyridamole in the treatment of a neonate with persistent pulmonary hypertension.
    Worwag S; Mulla H; Luyt D; Firmin RK
    J R Soc Med; 2000 Feb; 93(2):77-8. PubMed ID: 10740575
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhaled nitric oxide and oral nifedipine in a preterm infant with bronchopulmonary dysplasia and pulmonary hypertension.
    Rosati E; Butera G; Bossone E; De Felice C; Latini G
    Eur J Pediatr; 2007 Jul; 166(7):737-8. PubMed ID: 17103192
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of ARDS with nitric oxide and ECMO.
    Pappert D; Rossaint R; Falke K
    Int J Artif Organs; 1995 Oct; 18(10):611-9. PubMed ID: 8647593
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhaled nitric oxide potentiates actions of adenosine but not of sodium nitroprusside in experimental pulmonary hypertension.
    Patterson KW; Deb B; Kavanagh BP; Pearl RG
    Pharmacology; 1999 May; 58(5):246-51. PubMed ID: 10087465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe hypoxemia and pulmonary hypertension during orthotopic liver transplantation: a successful use of inhaled nitric oxide.
    Girardis M; Pasqualotto A; Colò F; Dal Pos L; Sabbadini D; Pasqualucci A; Pasetto A
    Intensive Care Med; 1999 Jun; 25(6):638. PubMed ID: 10416922
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhaled nitric oxide and heparin for infantile primary pulmonary hypertension.
    Atz AM; Wessel DL
    Lancet; 1998 Jun; 351(9117):1701. PubMed ID: 9734889
    [No Abstract]   [Full Text] [Related]  

  • 12. [Some aspects of clinical use of nitric oxide in pulmonary hypertension].
    Cheng X; He J
    Zhonghua Yi Xue Za Zhi; 1998 Jan; 78(1):6-7. PubMed ID: 10923395
    [No Abstract]   [Full Text] [Related]  

  • 13. Effective control of refractory pulmonary hypertension after cardiac operations.
    Fullerton DA; Jaggers J; Piedalue F; Grover FL; McIntyre RC
    J Thorac Cardiovasc Surg; 1997 Feb; 113(2):363-8; discussion 368-70. PubMed ID: 9040631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin.
    Tibballs J; Goh TH; McKenzie I; Hochmann M
    Anaesth Intensive Care; 1999 Jun; 27(3):316-7. PubMed ID: 10389572
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential.
    Ichinose F; Roberts JD; Zapol WM
    Circulation; 2004 Jun; 109(25):3106-11. PubMed ID: 15226227
    [No Abstract]   [Full Text] [Related]  

  • 16. Vardenafil and weaning from inhaled nitric oxide: effect on pulmonary hypertension in ARDS.
    Giacomini M; Borotto E; Bosotti L; Denkewitz T; Reali-Forster C; Carlucci P; Centanni S; Mantero A; Iapichino G
    Anaesth Intensive Care; 2007 Feb; 35(1):91-3. PubMed ID: 17323673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ECMO and inhaled nitric oxide for cardiopulmonary failure after heart retransplantation.
    Barzaghi N; Olivei M; Minzioni G; Degani A; Braschi A; Viganò M
    Ann Thorac Surg; 1997 Feb; 63(2):533-5. PubMed ID: 9033334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
    Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
    Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Safety of nitric oxide inhalation technique].
    Sun B
    Zhonghua Yi Xue Za Zhi; 1998 Jan; 78(1):8. PubMed ID: 10923396
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination of inhaled nitric oxide with i.v. nitroglycerin or with a prostacyclin analogue in the treatment of experimental pulmonary hypertension.
    Van Obbergh LJ; Charbonneau M; Blaise G
    Br J Anaesth; 1996 Aug; 77(2):227-31. PubMed ID: 8881631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.